Association of Voltage-Gated Sodium Channel Genetic Polymorphisms with Oxaliplatin-Induced Chronic Peripheral Neuropathy in South Indian Cancer Patients

Oxaliplatin is a platinum drug active against digestive tract cancers. Among its side effects, peripheral neuropathy is one of the dose-limiting toxicities. This affects around 50 to 70% of patients but the pathophysiology of development of oxaliplatin-induced peripheral neuropathy (OXAIPN) remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Palugulla, Sreenivasulu, Thakkar, Dimpal N, Kayal, Smita, Narayan, Sunil K, Dkhar, Steven Aibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773806/
https://www.ncbi.nlm.nih.gov/pubmed/29172294
http://dx.doi.org/10.22034/APJCP.2017.18.11.3157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773806/
https://www.ncbi.nlm.nih.gov/pubmed/29172294
http://dx.doi.org/10.22034/APJCP.2017.18.11.3157

Ejemplares similares